Filter News
Area of Research
- (-) Neutron Science (19)
- (-) Nuclear Science and Technology (5)
- Advanced Manufacturing (1)
- Biology and Environment (20)
- Clean Energy (29)
- Climate and Environmental Systems (1)
- Computational Engineering (1)
- Computer Science (4)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion and Fission (1)
- Isotopes (8)
- Materials (46)
- Materials for Computing (7)
- National Security (10)
- Quantum information Science (2)
- Supercomputing (44)
News Type
News Topics
- (-) Computer Science (7)
- (-) Environment (4)
- (-) Isotopes (2)
- (-) Physics (7)
- (-) Quantum Science (5)
- 3-D Printing/Advanced Manufacturing (5)
- Advanced Reactors (3)
- Artificial Intelligence (1)
- Big Data (1)
- Bioenergy (4)
- Biology (4)
- Biomedical (5)
- Biotechnology (1)
- Climate Change (1)
- Composites (1)
- Coronavirus (5)
- Cybersecurity (2)
- Decarbonization (2)
- Energy Storage (2)
- Frontier (1)
- Fusion (2)
- High-Performance Computing (1)
- Materials (6)
- Materials Science (14)
- Microscopy (1)
- Nanotechnology (7)
- National Security (1)
- Neutron Science (43)
- Nuclear Energy (10)
- Security (1)
- Space Exploration (3)
- Summit (4)
- Sustainable Energy (3)
- Transformational Challenge Reactor (1)
- Transportation (2)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
After more than a year of operation at the Department of Energy’s (DOE’s) Oak Ridge National Laboratory (ORNL), the COHERENT experiment, using the world’s smallest neutrino detector, has found a big fingerprint of the elusive, electrically neutral particles that interact only weakly with matter.